GlassScriptPhysician profile
Amy Jo Malone
NPI 1063412468
$8,631.74
in general payments reported to CMS, 2019-2025
50 companies · $2,364 in 2025
The $2,364 reported for 2025 was more than what 97% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,524 · 2022: $648 · 2023: $1,890 · 2024: $2,205 · 2025: $2,364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,994 · Education: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,994.15 |
| Education | $464.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $1,199.71 | 2021-2025 | Myrisk |
| Astrazeneca Pharmaceuticals LP | $839.81 | 2023-2025 | Imjudo, Imfinzi, Calquence |
| Glaxosmithkline, LLC. | $643.87 | 2021-2025 | Jemperli, Ojjaara, Zejula |
| Janssen Biotech, INC. | $571.55 | 2021-2025 | Tecvayli, Darzalex, Talvey |
| Lilly USA, LLC | $472.08 | 2021-2024 | Verzenio, Jaypirca, Retevmo |
| Regeneron Healthcare Solutions, INC. | $455.14 | 2023-2025 | Libtayo, Lynozyfic |
| Abbvie INC. | $447.70 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $383.86 | 2022-2025 | Opdivo |
| Incyte Corporation | $326.01 | 2021-2025 | Monjuvi, Jakafi, Pemazyre |
| Merck Sharp & Dohme LLC | $273.20 | 2022-2025 | Keytruda, Welireg, Lynparza |
| Merz North America, INC. | $230.11 | 2021-2023 | Xeomin |
| Beigene USA, INC. | $228.11 | 2021-2024 | Brukinsa |
| Tempus Ai, INC | $213.74 | 2024-2025 | Xt Cdx |
| Pfizer INC. | $208.67 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $181.73 | 2023-2025 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.